Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands
- PMID: 1684818
Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands
Abstract
The hemodynamic responses to 5'-N-ethylcarboxamide adenosine (NECA), a nonselective adenosine agonist, were compared to those elicited by the sodium salt of 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido adenosine (CGS 21680C) and N6-2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)-ethyl adenosine (CGS 24012), two structurally dissimilar selective A2 agonists in conscious spontaneously hypertensive rats (SHR). Dose-related reductions in mean arterial pressure occurred after bolus administration of NECA, CGS 21680C and CGS 24012. Dose-dependent tachycardia was seen with both CGS 21680C and CGS 24012, whereas NECA produced a biphasic response on heart rate. At high doses (3 and 10 micrograms/kg), NECA evoked an immediate and dramatic fall in heart rate, followed by a more gradual and long-lasting tachycardia. At equihypotensive doses, both CGS 21680C and CGS 24012 produced significant increases in cardiac output, but NECA had no effect. Although each of the adenosine agonists reduced total peripheral resistance, the greatest change was produced by CGS 21680C. Hindquarter, renal and mesenteric vascular resistances were significantly reduced by both CGS 21680C and CGS 24012, whereas only mesenteric vascular resistance was reduced with NECA. CGS 24012 reduced renal vascular resistance to the greatest extent and produced a concomitant significant increase in renal blood flow. Marked elevation in plasma renin activity occurred with CGS 24012 and CGS 21680C, whereas no change was seen after NECA. The hemodynamic responses to NECA, CGS 21680C and CGS 24012 were significantly reduced by the adenosine antagonist, 8-(p-sulfophenyl) theophylline, suggesting that these agents act through stimulation of adenosine receptors in the conscious SHR. Furthermore, blockade of the beta adrenergic receptor with metoprolol (1 mg/kg, i.v.) significantly attenuated the increase in heart rate produced by NECA, CGS 21680C and CGS 24012. The cardiovascular pattern of responses to the two selective A2 agonists, CGS 21680C and CGS 24012, are distinct from those of NECA, the nonselective adenosine agonist. The responses to both CGS 21680C and CGS 24012 indicate that systemic vasodilation, with resultant cardioexcitation and stimulation of renin release, are the predominant hemodynamic effects of selective A2 agonists in the conscious SHR. In contrast, the cardiovascular effects produced by NECA are mediated by activation of both A1 and A2 receptors.
Similar articles
-
Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.J Pharmacol Exp Ther. 1994 Mar;268(3):1506-11. J Pharmacol Exp Ther. 1994. PMID: 8138961
-
Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.J Pharmacol Exp Ther. 1995 Nov;275(2):914-9. J Pharmacol Exp Ther. 1995. PMID: 7473182
-
CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.J Pharmacol Exp Ther. 1989 Oct;251(1):47-55. J Pharmacol Exp Ther. 1989. PMID: 2795469
-
Purinergic mechanisms of the nucleus of the solitary tract and neural cardiovascular control.Neurol Res. 2005 Mar;27(2):182-94. doi: 10.1179/016164105X21959. Neurol Res. 2005. PMID: 15829182 Review.
-
Adenosine receptors in the central nervous system.J Neural Transm Suppl. 1991;34:149-55. doi: 10.1007/978-3-7091-9175-0_19. J Neural Transm Suppl. 1991. PMID: 1817158 Review.
Cited by
-
The discovery of a selective and potent A2a agonist with extended lung retention.Pharmacol Res Perspect. 2015 Jun;3(3):e00134. doi: 10.1002/prp2.134. Epub 2015 May 4. Pharmacol Res Perspect. 2015. PMID: 26236482 Free PMC article.
-
Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.Br J Pharmacol. 1996 May;118(2):369-77. doi: 10.1111/j.1476-5381.1996.tb15412.x. Br J Pharmacol. 1996. PMID: 8735640 Free PMC article.
-
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.Br J Pharmacol. 1995 Feb;114(4):761-8. doi: 10.1111/j.1476-5381.1995.tb13270.x. Br J Pharmacol. 1995. PMID: 7773536 Free PMC article.
-
Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum.Mol Pharm. 2022 Aug 1;19(8):2992-3001. doi: 10.1021/acs.molpharmaceut.2c00450. Epub 2022 Jul 18. Mol Pharm. 2022. PMID: 35849844 Free PMC article.
-
Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.Br J Pharmacol. 1995 Oct;116(3):1957-64. doi: 10.1111/j.1476-5381.1995.tb16398.x. Br J Pharmacol. 1995. PMID: 8640332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources